Long-term clinical outcomes in older patients with acute venous thromboembolism who have renal impairment.

Messi, Mia; Beneyto Afonso, Carlota; Stalder, Odile; Méan, Marie; Righini, Marc; Rodondi, Nicolas; Aujesky, Drahomir (2022). Long-term clinical outcomes in older patients with acute venous thromboembolism who have renal impairment. Thrombosis research, 218, pp. 64-71. Elsevier 10.1016/j.thromres.2022.08.001

[img] Text
1-s2.0-S0049384822003346-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (911kB) | Request a copy
[img]
Preview
Text
Messi_ThrombRes_2022_AAM.pdf - Accepted Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (780kB) | Preview

INTRODUCTION

Renal impairment (RI) may induce an inflammatory/procoagulant state as well as platelet dysfunction. Little is known on the prevalence of RI and long-term prognosis of older patients with venous thromboembolism (VTE) who have concomitant RI.

METHODS

In a prospective multicenter cohort, we analyzed 912 patients aged ≥65 years with acute VTE. Using the CKD-EPI formula, we defined three categories of baseline renal function: estimated glomerular filtration rate ≥60 ml/min/1.73m2 (no RI), 30-59 ml/min/1.73m2 (moderate RI), and <30 ml/min/1.73m2 (severe RI). The outcomes were VTE recurrence, major bleeding, and overall mortality. We examined the association between renal function and clinical outcomes using competing risk regression models, adjusting for relevant confounders and periods of anticoagulation.

RESULTS

We followed 912 patients over a median duration of 29.6 months. Overall, 313 (34%) patients had moderate and 51 (6%) severe RI. One hundred and seven patients (12%) had VTE recurrence, 125 (14%) had major bleeding, and 186 (20%) died during follow-up. After adjustment, severe RI was associated with a 2-fold increased risk of major bleeding (sub-hazard ratio [SHR] 2.1, 95% CI 1.1-4.0) compared to no RI, but not with VTE recurrence (SHR 0.6, 95% CI 0.2-1.8) or overall mortality (hazard ratio 1.0, 95% CI 0.6-1.9). Moderate RI was not significantly associated with adverse clinical outcomes.

CONCLUSIONS

RI was common among older patients with acute VTE. Severe RI was associated with a 2-fold increased long-term risk of major bleeding, without a risk increase in terms of VTE recurrence and overall mortality. Older patients with moderate RI did not carry worse prognosis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine
04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine > Centre of Competence for General Internal Medicine
04 Faculty of Medicine > Medical Education > Institute of General Practice and Primary Care (BIHAM)
04 Faculty of Medicine > Pre-clinic Human Medicine > Department of Clinical Research (DCR)

UniBE Contributor:

Messi, Mia, Beneyto Afonso, Carlota, Stalder, Odile, Rodondi, Nicolas, Aujesky, Drahomir

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

0049-3848

Publisher:

Elsevier

Funders:

[4] Swiss National Science Foundation

Language:

English

Submitter:

Pubmed Import

Date Deposited:

24 Aug 2022 14:17

Last Modified:

20 Feb 2024 14:15

Publisher DOI:

10.1016/j.thromres.2022.08.001

PubMed ID:

35994838

Uncontrolled Keywords:

Anticoagulation Elderly Prognosis Renal impairment Venous thromboembolism

BORIS DOI:

10.48350/172254

URI:

https://boris.unibe.ch/id/eprint/172254

Actions (login required)

Edit item Edit item
Provide Feedback